Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method

Biomaterials

Volumn 24, Issue 13, 2003, Pages 2323-2329

  Yoon, Jun Jin ^a   Kim, Jung Hoe ^a   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Biodegradable polymer; Dexamethasone; Scaffolds; Sustained release

Indexed keywords

BIODEGRADATION; DRUG PRODUCTS; POLYMERS; SCAFFOLDS;

LYMPHOCYTES;

BIOMATERIALS;

DEXAMETHASONE; POLYGLACTIN; POLYMER; SODIUM CHLORIDE;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISSOLUTION; DRUG EFFECT; DRUG EFFICACY; DRUG SYNTHESIS; FOAMING; GAS; HYPOTHESIS; LEACHING; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; STENT; SUSTAINED DRUG RELEASE; TECHNIQUE;

EID: 0037409914     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00024-3     Document Type: Article

References (32)

1. Nam Y.S., Yoon J.J., Park T.G. A novel fabrication method for macroporous scaffolds using gas foaming salt as porogen additive. J Biomed Mater Res (Appl Biomater). 53:2000;1-7.
2. Yoon J.J., Park T.G. Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res. 55:2001;401-408.
3. Baek C.H., Lee J.C., Ko Y.J., Yoon J.J., Park T.G. Tissue engineered cartilage on the poly(D,L-lactic-co-glycolic acid) scaffolds. cell shape and phenotypic expression in vitro Laryngoscope. 112:2002;1050-1055.
4. Yoon J.J., Nam Y.S., Kim J.H., Park T.G. Surface immobilization of galactose onto aliphatic biodegradable polymer for hepatocyte culture. Biotechnol Bioeng. 78:2002;1-10.
5. Park T.G. Perfusion culture of hepatocytes within galactose-derivatized biodegradable poly(lactide-co-glycolide) scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res. 59:2002;127-135.
6. Tabata Y. The importance of drug delivery systems in tissue engineering. Pharm Sci Technol Today. 3:2000;80-89.
7. Lo H., Kadiyala S., Guggino S.E., Leong K.W. Poly(L-lactic acid) foams with cell seeding and controlled-release capacity. J Biomed Mater Res. 30:1996;475-484.
8. Whang K., Goldstick T.K., Healy K.E. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials. 21:2000;2545-2551.
9. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nature Biotechnol. 19:2001;1029-1034.
10. Mooney D.J., Kaufmann P.M., Sano K., Schwendeman S.P., Majahod Schloo B., Vacanti J.P., Langer R. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Biotechnol Bioeng. 50:1996;422-429.
11. Vehof J.W.M., Fisher J.P., Dean D., van der Waerden J.P.C.M., Spauwen P.H.M., Mikos A.G., Jansen J.A. Bone formation in transforming growth factor β-1-coated porous poly(propylene fumarate) scaffolds. J Biomed Mater Res. 60:2002;241-251.
12. Wissink M.J.B., Beernink R., Poot A.A., Engbers G.H.M., Beugeling T., van Aken W.G., Feijen J. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release. 64:2000;103-114.
13. Sheridan M.H., Shea L.D., Peters M.C., Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release. 64:2000;91-102.
14. Murphy W.L., Peters M.C., Kohn D.C., Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 21:2000;2521-2527.
15. Lee S.C., Shea M., Battle M.A. Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix. J Biomed Mater Res. 28:1994;1149-1156.
16. Smith J.L., Jin L., Parsons T. Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2). J Control Release. 36:1995;183-195.
17. Kawamura M., Hatanaka K., Saito M., Ogino M., Ono T., Ogino K., Matsuo S., Harada Y. Are the anti-inflammatory effects of dexamethasone responsible for inhibition of the induction of enzymes involved in prostanoid formation in rat carrageenin-induced pleurisy? Eur J Pharmacol. 400:2000;127-135.
18. Hickey T., Kreutzer D., Burgess D.J., Moussy F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res. 61:2002;180-187.
19. Hickey T., Kreutzer D., Burgess D.J., Moussy F. Dexamethason/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 23:2002;1649-1656.
20. Reil T.D., Sarkar R., Kashyap V.S., Sarkar M., Gelabert H.A. Dexamethasone suppresses vascular smooth muscle cell proliferation. J Surg Res. 85:1999;109-114.
21. Lincoff A.M., Frust J.G., Ellis S.G., Tuch R.J., Topol E.J. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restinosis in the porcine coronary injury model. J Am Coll Cardiol. 29:1997;808-816.
22. Villa A.E., Guzman L.A., Chen W., Golomb G., Levy R.J., Topol E.J. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest. 93(3):1994;1243-1249.
23. Dixon E.R., Weinberg J.A., Lew D.B. Effect of dexamethasone on bovine airway smooth muscle cell proliferation. J Asthma. 36:1999;519-525.
24. Matsumura M., Kakishita H., Suzuki M., Banba N., Hattori Y. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci. 69:2001;1067-1077.
25. Dev V., Eigler N., Fishbein M.C., Tian Y., Hickey A., Rechavia E., Forrester J.S., Litvack F. Sustained local drug delivery to the arterial wall via biodegradable microspheres. Cathet Cardiovasc Diagn. 41:1997;324-332.
26. Eroglu H., Kas H.S., Oner L., Turkoglu O.F., Akalan N., Sargon M.F., Ozer N. The in-vitro and in-vivo characterization of PLGA. L-PLA microspheres containing dexamethasone sodium phosphate J Microencapsul. 18:2001;603-612.
27. Zilberman M., Schwade N.D., Meidell R.S., Eberhart R.C. Structured drug-loaded bioresorbable films for support structures. J Biomater Sci Polym Ed. 12:2001;875-892.
28. Tsung M.J., Burgess D.J. Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS PharmSci. 3:2001;E11.
29. Peter S.J., Liang C.R., Kim D.J., Widmer M.S., Mikos A.G. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, β-glycerolphosphate, and L-ascorbic acid. J Cell Biochem. 71:1998;55-62.
30. Martin I., Shastri V.P., Padera R.F., Yang J., Mackay A.J., Langer R., Vunjak-Novakovic G., Freed L.E. Selective differentiation of mammalian bone marrow stromal cells cultured on three-dimensional polymer foams. J Biomed Mater Res. 55:2001;229-235.
31. Blauer K.L., Poth M., Rogers W.M., Bernton E.W. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology. 129:1991;3174-3179.
32. Kunou N., Ogura Y., Honda Y., Hyon S.H., Ikada Y. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate. J Biomed Mater Res. 51:2000;635-641.